The effect of the aerial mycelium-inducing compound, pamamycin-607, on antibiotic production by several Streptomyces spp. was examined. Exposure to 6.6 M pamamycin-607 stimulated by 2.7 fold the puromycin production by Streptomyces alboniger NBRC 12738, in which pamamycin-607 had first been isolated, and restored aerial mycelium formation. Pamamycin-607 also stimulated the respective production of streptomycin by S. griseus NBRC 12875 and that of cinerubins A and B by S. tauricus JCM 4837 by approximately 1.5, 1.7 and 1.9 fold. The antibiotic produced by Streptomyces sp. 91-a was identified as virginiamycin M 1 , and its synthesis was enhanced 2.6 fold by pamamycin-607. These results demonstrate that pamamycin-607 not only restored or stimulated aerial mycelium formation, but also stimulated secondary metabolite production.
Streptomyces is an industrially important genus of microorganisms that produce a wide variety of bioactive metabolites such as antibiotics, antitumor agents, enzyme inhibitors, herbicides, and insecticides. Although they are prokaryotes, Streptomyces spp. exhibit a life cycle which is similar to that of eukaryotic fungi on an agar medium: germinated spores first extend substrate mycelia on the surface and into the medium, and under appropriate conditions, aerial mycelia then differentiate from the substrate mycelia into the air. The subsequent septation of aerial mycelia produces spores to complete the life cycle of these microorganisms. The differentiation of aerial mycelia from substrate mycelia results in dramatic changes in the colony appearance such as color and texture.
A close relationship exists between secondary metabolite production and morphological differentiation in Streptomyces spp. For example, Perlman et al. 1) have reported that streptomycin production by a mutant of Streptomyces griseus markedly decreased as cells were repeatedly transferred in submerged cultures, and that the loss of antibiotic-producing capacity was correlated with the occurrence of non-sporulating colonial types which did not produce streptomycin. In addition, Ginther 2) has demonstrated that spontaneous mutants of S. lactamdurans which failed to form aerial mycelia also did not produce cephamycin C. These observations indicate that dynamic metabolic changes in Streptomyces spp. occur upon the differentiation of aerial mycelia.
Pamamycin-607 ( Fig. 1) is an aerial mycelium-inducing substance that was first isolated from Streptomyces alboniger. [3] [4] [5] [6] Although pamamycin-607 is only produced by a limited number of species, it restores or stimulates the formation of aerial mycelia in many Streptomyces spp., and also affects secondary metabolite production in several strains. 7) We examine here the effect of pamamycin-607 on the regulation of secondary metabolism. We first screened Streptomyces strains whose antibiotic activity against Staphylococcus aureus and aerial mycelium formation was affected by pamamycin-607 from newly isolated actinomycete strains, because specimens examined in the previous study 7) were those that had been deposited in culture collections, and then quantitatively evaluated the stimulatory effect of pamamycin-607 on antibiotic production by the strains found in this and previous studies.
Results and Discussion
Screening Streptomyces strains that responded to pamamycin-607
We examined the effect of pamamycin-607 on 19 uncharacterized actinomycete strains isolated from soil samples by the same paper disc method (10 mg of pamamycin-607/disc) as that used in our previous study.
7 ) The result of this screening on a yeast extractmalt extract agar (YMA) medium showed that aerial mycelia were restored in 12 strains (63%) and stimulated in 3 strains (16%) upon exposure to pamamycin-607 (Supplemental Table 1 ; see Biosci. Biotechnol. Biochem. Web site). The percentage of strains whose aerial mycelia were induced or stimulated was similar to that found in our previous study; pamamycin-607 restored or stimulated aerial mycelium formation in 30 strains (67%) of the 45 strains examined. 7) Among the strains whose aerial mycelium formation was affected by pamamycin-607, antibiotic production was detected in 7 strains (Table 1 ). The effect of pamamycin-607 on antibiotic production by these 7 strains was next examined by the agar disc method. 7) Following exposure to pamamycin-607, a distinct increase and decrease of the antibacterial zones were respectively observed for strains 91-a and 53-a, this being accompanied by the restoration of aerial mycelium formation (Table 1 , Fig. 2 ). We revealed in the previous study 7) that pamamycin-607 enhanced antibiotic production in S. alboniger NBRC 12738, S. griseus NBRC 12875, and S. tauricus JCM 4837, but decreased antibiotic production in S. ambofaciens JCM 4204 and S. griseus NBRC 3237 (Table 1) . These results show that pamamycin-607 affected not only morphological differentiation, but also secondary metabolism in these actinomycete strains.
Identification of antibiotics produced by S. tauricus JCM 4837
Prior to investigating the effects of pamamycin-607 on antibiotic production, the antibiotics produced by S. tauricus JCM 4837 were purified and identified, as it is known that S. tauricus produces several types of antibiotics, including tauromycetin (structure unknown), 8) taurimycins A and B, 9) -rubromycin, 10) and MS-282.
11)
S. tauricus JCM 4837 treated with pamamycin-607 increased the production of a diffusible red pigment (Fig. 2) . Our preliminary study showed that this red pigment was an antibacterial substance, as had been expected from the fact that taurimycins and -rubromycin were red in color. We searched for a more suitable medium for the antibiotic production by S. tauricus JCM 4837 without adding pamamycin-607, because antibiotic production was relatively poor when using the YMA medium, in which a restorative effect of pamamycin-607 on aerial mycelia was observed. We selected a soybean flour-containing medium 10) that was favorable for the mass production of the red-colored antibiotics produced in the YMA medium.
The cultured material of S. tauricus JCM 4837 was purified by EtOAc extraction and then subjected to silica gel column chromatography and preparative thin-layer chromatography (TLC), this resulting in the purification of 2 red-colored antibiotics, designated P-1 and P-2. 12) and suggested the presence of a "-pyroromycinone aglycone. P-1 showed an ion at m=z 826.3 in the positive mode and at m=z 824.3 in the negative mode of liquid chromatographyelectrospray ionization-mass spectrometry (LC-ESI-MS), and its molecular weight (MW) was determined to be 825. Two anthraquinone antibiotics containing an "-pyroromycinone aglycone with MW 825 have been reported: cinerubin B 13) (antibiotic 80334A 14) ) and its 5 000 epimer, antibiotic 80334B 14) (spartanamycin A 15) ). As the 5 000 -H ( H 4.78, q, J ¼ 6:0 Hz) and 6 000 -CH 3 ( H 1.34, d, J ¼ 6:0 Hz) signals of purified P-1 coincided well with those of cinerubin B, P-1 was identified as cinerubin B (Table 2) , differently from the reported antibiotics in the previous papers.
P-2 displayed an identical UV spectrum to that of P-1, and its MW was determined to be 827 from the ½M þ H þ ion at m=z 828.1. 1 H-NMR data for P-2 agreed well with those of cinerubin A 16) (spartanamycin B 15) ); P-2 was therefore identified as cinerubin A ( Table 2) .
Identification of antibiotics produced by Streptomyces sp. 91-a
The antibiotic produced by strain 91-a was isolated by silica gel column chromatography, preparative TLC, and ODS-HPLC. The purified antibiotic showed cationized molecules at m=z 548.
in the LC-ESI-MS data and an accurate mass of the ½M þ Na þ ion was observed at m=z 548.2408 (calcd. 548.2372 for C 28 H 35 N 3 O 7 Na). Based on a search of the SciFinder database using the deduced molecular formulae, and subsequent search refinement of candidates from the characteristic signals in the 1 H-NMR spectrum (7 olefinic protons, 6 protons adjacent to hetero-atoms ( H 3.5-5.0), and 3 doublet methyl protons), the antibiotic was speculated to be virginiamycin M 1 (staphylomycin M 1 ). 17) All of the expected cross-peaks for the structure of virginiamycin M 1 , other than an H4-H5 correlation in the 5-hydroxy-4,6-dimethylhept-2-enoic acid part of the molecule, were apparent in the 1 H-1 H COSY spectrum. Furthermore, identical retention times and UV spectra for HPLC analysis and identical 1 H-NMR spectra were obtained with the isolated antibiotic and an authentic sample of virginiamycin M 1 . The antibiotic produced by Streptomyces sp. 91-a was therefore identified as virginiamycin M 1 (Table 2 ).
An analysis of the 16S rDNA gene sequences through a BLAST 18) homology search of the GenBank database revealed that strain 91-a was most closely related to S. subrutilus DSM 40445 T (99.7% homology).
Effect of pamamycin-607 on antibiotic production Antibiotic production was quantitatively evaluated for 4 Streptomyces strains whose antibacterial activity had been markedly stimulated by pamamycin-607 (Table 1) . The Streptomyces strains were cultured in the agar medium indicated in Table 1 in the presence (6.6 mM) or absence of pamamycin-607, and the produced antibiotics were extracted and analyzed. Puromycin production by S. alboniger and cinerubin production by S. tauricus were respectively determined with HPLC at UV 270 and 233 nm (Supplemental Fig. 1 ). To determine the streptomycin production in S. griseus, an aqueous extract from the cultured material of this species was purified by using a cation-exchange resin column and ion-pair solid-phase extraction (Supplemental Fig. 2 ), and then analyzed by LC-MS-SIM at m=z 582 (½M þ H þ ). Virginiamycin M 1 production by Streptomyces sp. 91-a was determined by LC-MS-SIM at m=z 548 (½M þ Na þ ). The antibiotic production is shown as the amount of antibiotic per volume of medium, because a reproducible mycelial amount could not be obtained.
Pamamycin-607 increased the puromycin production by 2.7 fold in the pamamycin-producer, S. alboniger, and also increased the synthesis of 4 antibiotics by 1.5-2.6 fold in the 3 other Streptomyces species examined ( Table 2 ).
The structures of the induced antibiotics are diverse, so it is likely that pamamycin-607 acted on the widely conserved regulatory system of secondary metabolite production or on a commonly required metabolic pathway for antibiotic synthesis such as that associated with the energy generation system. This speculation is in accordance with the finding 7) that pamamycin-607 restored or stimulated aerial mycelium formation in numerous Streptomyces species, irrespective of pamamycin-607 productivity. We have shown 19) that pamamycin-607 induced a transient increase in intracellular calcium concentration in S. alboniger, suggesting that pamamycin-607 may have acted on a signal transduction cascade.
In contrast, the antibiotic production of some species was reduced by pamamycin-607, and a different response to pamamycin-607 was found among strains of the same species such as S. griseus (Table 1) . We have no information at this stage about secondary metabolites other than those with antibiotic activity against Staphylococcus aureus and the antibiotic produced by S. griseus NBRC 3237. The effect of pamamycin-607 on the production of those metabolites is also not known. Clarification of these aspects is required for a realistic discussion on the mode of action of pamamycin-607.
Butyrolactone-type regulatory molecules are well known for controlling morphological differentiation and/or secondary metabolite production in Streptomyces spp. 20) Among these compounds, A-factor regulates spore formation, streptomycin and pigment production, and self-resistance to streptomycin in S. griseus, while virginiae butanolide induces staphylomycin production in S. virginiae. These two regulatory molecules have similar structures and modes of action, functioning as agonists of repressor-type receptor proteins, but strictly recognize their individual receptors and do not exhibit cross activity. 20) Pamamycin-607 showed similar activities to those of the butyrolactone regulators in Streptomyces spp., but had an entirely different structure. The wide spectrum of activity that pamamycin-607 exerted on morphological differentiation and secondary metabolite production in many Streptomyces strains is of great interest for bioactive metabolite production, and elucidating its mode of action is required in future studies.
Experimental
Bacterial strains and media. The bacterial strains used in this study are listed in Table 1 and Supplemental Table 1 . The strains in Supplemental Table 1 , including the initial 7 strains (strains 42-c to 101-d) in Table 1 , were isolated from soil samples collected at our university. The taxonomy of strain 91-a was examined at TechnoSuruga Laboratory (Shizuoka, Japan) by analyzing the 16S rDNA sequence (1485 bp). The yeast extract-malt extract agar (YMA), oatmeal agar (OMA), and inorganic salt-starch agar (ISS) media were purchased from Wako Pure Chemical Industries (Osaka, Japan).
Antibacterial activity was examined as previously described by using an agar diffusion assay with a nutrient agar medium and S. aureus NBRC 12732 as the test organism.
7)
Instrumental analyses. HPLC analyses were performed by an LC-10 system (Shimadzu, Kyoto, Japan) equipped with an SPD-M10A photodiode array detector. LC-MS data were measured by electrospray ionization with a JMS-T100LC system (Jeol, Tokyo, Japan). The analytical conditions used for the HPLC and LC-MS analyses are described in the following sections. NMR spectra were recorded with a JNM AL-400 or JNM A600 spectrometer (Jeol) in CDCl 3 , using CHCl 3 H 7.24 as the internal standard.
Isolation of antibiotics produced by S. tauricus. S. tauricus JCM4837 was cultured at 28 C for 7 d on an agar medium consisting of 2.5% soluble-starch, 1.5% soybean flour, 0.2% yeast extract, 0.2% (NH 4 ) 2 SO 4 , 0.5% NaCl, and 0.4% CaCO 3 .
10) The cultured material (400 mL) was macerated in acetone and then allowed to stand for 1 d at room temperature. The acetone extract was collected by decantation, and the residual cultured material was treated with 60% aq. acetone for 1 d at room temperature. The second acetone extract was collected, combined with the first extract, and then concentrated in vacuo to an aqueous residue. The residual solution was treated with EtOAc, and the EtOAc extract was purified by silica gel column chromatography; after washing the column with CHCl 3 , two red-colored antibiotics (P-1 and P-2) were respectively eluted with 1% and 3% MeOH-CHCl 3 . Antibiotic P-1 (1.10 mg) was isolated from the 1% MeOH-CHCl 3 fraction by preparative TLC with MeOH-benzene (1:1), while P-2 (0.98 mg) was isolated from the 3% MeOH-CHCl 3 fraction by preparative TLC with MeOH-CHCl 3 (5:95).
Isolation of the antibiotic produced by Streptomyces sp. 91-a. Streptomyces strain 91-a was cultured on a YMA medium at 28 C for 7 d, and 1500 mL of the cultured material was sequentially treated with MeOH and EtOAc as just described to obtain an EtOAc-soluble neutral extract. This extract was applied to a column of silica gel, which was then washed with CHCl 3 , and the antibiotic was eluted with 5% MeOH-CHCl 3 . The active fraction was purified by preparative silica gel TLC (5% MeOH-CHCl 3 ), and the fluorescent band at R f ¼ 0:28 was collected. The fraction was purified twice by HPLC (Develosil ODS-UG-5 column (4:6 Â 250 mm); 55% aq. CH 3 CN solvent; 1.0 mL/min flow rate; UV detection at 240 nm; t R 4.7 min), and the pure antibiotic (0.56 mg) was obtained.
Treatment of Streptomyces strains with pamamycin-607. Pamamycin-607 was isolated from the cultured material of S. alboniger NBRC 12738 in our laboratory as previously described. 4, 21) An acetone solution (80 mL) of pamamycin-607 (0.5 mg/mL) was applied to the surface of an agar medium (10 mL, Table 1 ) in a Petri dish (9 cm in diameter), and acetone was removed by evaporating in a clean bench to give a 6.6 mM final concentration of pamamycin-607. Agar plates were then inoculated with each Streptomyces strain to be evaluated, and were incubated at 28 C for 7 d.
Extraction and quantitative analysis of puromycin. The cultured material of S. alboniger NBRC 12738 was collected from 3 Petri dishes that had been treated with or without pamamycin-607, macerated in acetone, and extracted with acetone as just described for S. tauricus. The aqueous residue of the acetone extract was treated with EtOAc to remove the lipophilic impurities, and the aqueous phase was lyophilized. The resulting residue was dissolved in the mobile phase of the HPLC system and analyzed under the following conditions: Develosil ODS-UG-5 column (4:6 Â 250 mm); CH 3 CN-0.1% aq. NH 4 OAc (25:75) solvent; 1 mL/min flow rate; UV detection at 270 nm; t R 7.5 min for puromycin. The amount of puromycin was calculated from the peak area with a calibration curve generated by using standard puromycin (Wako Pure Chemical Industries). The cultivation and extraction of the antibiotic was conducted twice, and a quantitative analysis was performed three times for each sample (Supplemental Table 2 ).
Extraction and quantitative analysis of streptomycin. The cultured material of S. griseus NBRC 12875 was collected from three Petri dishes, macerated in sterile deionized water and then allowed to stand for 1 d at room temperature. Agar was removed by filtration, and the aqueous extract was purified by using a combination of cationexchange resin columns and ion-pair solid-phase extraction by respective modification of the methods of Kaufmann et al. 22) and Horie et al. 23) (Supplemental Fig. 2 ). The lyophilized material was dissolved in the mobile phase of the HPLC system and analyzed by the LC-MS-SIM method 22) under the following conditions: Develosil ODS-UG-5 column (2:0 Â 150 mm); CH 3 CN-5 mM aq. heptafluorobutyric acid solvent (20:80); 0.18 mL/min flow rate; detection by SIM at m=z 582 ½M þ H þ ; t R 5.0 min for streptomycin). The amount of streptomycin was calculated from the peak area with a calibration curve generated by using standard streptomycin (Wako Pure Chemical Industries).
Extraction and quantitative analysis of antibiotics produced by S. tauricus. The cultured material of S. tauricus JCM4837 collected from three Petri dishes was treated with acetone and EtOAc as just described. The EtOAc-soluble extract was purified by silica gel column chromatography; after washing the column with CHCl 3 , antibiotics P-1 (cinerubin B) and P-2 (cinerubin A) were respectively eluted with 1% and 3% MeOH-CHCl 3 . The amount of the two antibiotics in these fractions was measured by HPLC under the following conditions: Develosil ODS-UG-5 column (2:0 Â 150 mm); CH 3 CN-50 mM phosphate buffer solvent at pH 7.0 (70:30); 0.2 mL/min flow rate; UV detection at 233 nm; t R 10.0 min for P-1 (cinerubin B) and 6.4 min for P-2 (cinerubin A). A calibration curve for quantitative analysis was generated by using the isolated cinerubines as standards.
Extraction and quantitative analysis of antibiotics produced by Streptomyces sp. 91-a. An EtOAc-soluble extract was obtained from the cultured material of strain 91-a in a similar manner to that described for extracting the antibiotics produced by S. tauricus. The amount of antibiotic (virginiamycin M 1 ) in the extract was measured by the LC-MS-SIM method under the following conditions: Develosil ODS-UG-5 column (2:0 Â 150 mm); CH 3 CN-H 2 O solvent (55:45); 0.2 mL/min flow rate; SIM detection at m=z 548 ½M þ Na þ ; t R 3.3 min for virginiamycin M 1 .
